Gene: WIPF2
Official Full Name: WAS/WASL interacting protein family member 2provided by HGNC
Gene Summary: This gene encodes a WASP interacting protein (WIP)-related protein. It has been shown that this protein has a role in the WASP-mediated organization of the actin cytoskeleton and that this protein is a potential link between the activated platelet-derived growth factor receptor and the actin polymerization machinery. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO23835 | WIPF2 Knockout cell line (HeLa) | Human | WIPF2 | 1:3~1:6 | Negative | Online Inquiry |
KO23836 | WIPF2 Knockout cell line (HCT 116) | Human | WIPF2 | 1:2~1:4 | Negative | Online Inquiry |
KO23837 | WIPF2 Knockout cell line (HEK293) | Human | WIPF2 | 1:3~1:6 | Negative | Online Inquiry |
KO23838 | WIPF2 Knockout cell line (A549) | Human | WIPF2 | 1:3~1:4 | Negative | Online Inquiry |
WIPF2 Gene Knockout Cell Lines are specialized cellular models designed to investigate the functional role of the WIPF2 gene, which encodes a protein involved in cytoskeletal dynamics and cellular signaling pathways. These cell lines are generated through precision genome editing techniques, such as CRISPR/Cas9, resulting in the complete knockout of WIPF2 expression. By effectively disrupting the gene's function, researchers can elucidate the precise biological mechanisms influenced by WIPF2 and its implications in various physiological processes as well as disease states.
The primary mechanisms through which WIPF2 knockout cell lines operate include the alteration of cellular morphology, migration patterns, and signaling cascades that are essential for numerous cellular functions. Researchers can utilize these models to explore the gene's involvement in actin filament organization, endocytosis, and the modulation of cellular responses to external stimuli. Such insights are crucial for understanding diseases characterized by dysregulated cellular dynamics, including cancer progression and neurodegeneration.
In both research and clinical settings, WIPF2 Gene Knockout Cell Lines serve as a critical tool for identifying therapeutic targets and biomarkers. The unique ability to directly observe the effects of WIPF2 loss makes these models indispensable for drug discovery and validation processes, paving the way for the development of novel interventions.
Compared to alternative models, such as transient knockdown approaches, WIPF2 knockout cell lines provide a more stable and reproducible system for assessing the long-term effects of WIPF2 loss, thus enhancing the reliability of experimental outcomes. Their application in various cell types allows for versatile experimental designs tailored to specific research questions.
For researchers and clinicians alike, the value of WIPF2 Gene Knockout Cell Lines lies in their contributions to advancing our understanding of gene function, disease mechanisms, and potential therapeutic strategies. Our company prides itself on delivering high-quality biological products, backed by years of expertise in genetic engineering and cell line development, ensuring that our customers have the tools they need to make groundbreaking discoveries in the life sciences.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.